Cargando…
A patient-tailored approach for corticosteroid treatment in COVID-19: still not there yet
Other steroids are currently not superior to dexamethasone 6 mg in COVID-19 patients with acute respiratory failure https://bit.ly/3YUkc8G
Autores principales: | Nigro, Mattia, Chalmers, James D., Aliberti, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116062/ https://www.ncbi.nlm.nih.gov/pubmed/36858444 http://dx.doi.org/10.1183/13993003.00270-2023 |
Ejemplares similares
-
Get together to increase awareness in bronchiectasis: a report of the 2(nd) World Bronchiectasis Conference
por: Aliberti, Stefano, et al.
Publicado: (2018) -
Tailoring treatments to older people in intensive care. A way forward
por: Aliberti, Márlon Juliano Romero, et al.
Publicado: (2022) -
Lipoprotein (a)—We Know So Much Yet Still Have Much to Learn …
por: Banach, Maciej
Publicado: (2016) -
Evaluation of LA Dynamics: a Classical Yet Still Challenging Topic until Now
por: Yoon, Se-Jung
Publicado: (2022) -
The COVID‐19 world – Are we there yet?
por: Hamamoto, Yoshiyuki
Publicado: (2021)